SOPHARMA AD - Notification for buy-back shares

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Current report_230_buy back_espi.pdf Notification for buy-back shares
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 230 / 2023

Date of issue: 2023-12-14

Short name of the issuer

SOPHARMA AD

Subject

Notification for buy-back shares

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 13, 2023 the Company bought 184 000 (one hundred and eighty-four thousand) own shares representing 0.107% of the share capital of the Company, at a total value of BGN 1 122 400 on the Bulgarian Stock Exchange, the average price per share was BGN 6,10.
The total number of treasury shares after this transaction is 14,229,188 representing 8.244% of the share capital of the Company.

Annexes

File Description

Current report_230_buy back_espi.pdfCurrent report_230_buy back_espi.pdf Notification for buy-back shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-12-14 Ognian Donev Executive Director